Top Markets
Coin of the day
PCI Biotech Holding ASA PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCIB
Clasificación en acciones #40012
PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is... PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is focused on pioneering and bringing to market innovative treatments for cancer. At the core of their operations is the proprietary photochemical internalization (PCI) technology platform. The company's development pipeline features several distinct therapeutic strategies: fimaCHEM, a novel approach to chemotherapeutic cancer treatment; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is currently in Phase I clinical studies; and fimaNAc, a delivery system for nucleic acid therapeutics, presently in its pre-clinical phase. Furthermore, they provide Amphinex, a photosensitizer known as fimaporfin. PCI Biotech actively participates in joint research endeavors with partners such as Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense.
Precio por acción
$0.00733708
Última sincronización: 2026-04-23
Capitalización bursátil
$273.87K
Cambio (1 día)
-39.13%
Cambio (1 año)
-94.83%
País
NO
Comercio PCI Biotech Holding ASA (PCIB)

Categoría

Historial de desdoblamientos de acciones de PCI Biotech Holding ASA (PCIB)
La acción PCI Biotech Holding ASA (símbolo: PCIB) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 14, 2026.
Una acción PCIB comprada antes de Aug 14, 2026 equivaldría hoy a 0 acciones PCIB.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE